Lobular neoplasia of the breast revisited with emphasis on the role of e-cadherin immunohistochemistry Journal Article


Authors: Dabbs, D. J.; Schnitt, S. J.; Geyer, F. C.; Weigelt, B.; Baehner, F. L.; Decker, T.; Eusebi, V.; Fox, S. B.; Ichihara, S.; Lakhani, S. R.; Palacios, J.; Rakha, E.; Richardson, A. L.; Schmitt, F. C.; Tan, P. H.; Tse, G. M.; Vincent-Salomon, A.; Ellis, I. O.; Badve, S.; Reis-Filho, J. S.
Article Title: Lobular neoplasia of the breast revisited with emphasis on the role of e-cadherin immunohistochemistry
Abstract: Lobular neoplasia (LN) is a term that encompasses both lobular carcinoma in situ and atypical lobular hyperplasia. These lesions have been shown to constitute both risk indicators and nonobligate precursors of invasive breast cancer, they are relatively uncommon, and are most often identified in specimens taken for other reasons. Their incidence has increased in the last 2 decades, and novel variants, including a pleomorphic type, have been described. Loss of E-cadherin expression is recognized as a hallmark diagnostic feature of LN and invasive lobular carcinomas, and immunohistochemical (IHC) analysis using anti-E-cadherin antibodies has been proven to be a useful method to differentiate between lobular and ductal lesions. The frequent use of E-cadherin IHC analysis in routine diagnostic histopathology, however, has resulted in confusion with regard to the actual value of IHC with antibodies against E-cadherin and other proteins of the cadherincatenin complex. This review provides an update on recent clinicopathologic and molecular data on LN and invasive lobular carcinoma and a discussion about the use and limitations of IHC with E-cadherin in diagnostic breast pathology. © 2013 Lippincott Williams and Wilkins.
Keywords: immunohistochemistry; gene expression profiling; comparative genomic hybridization; lobular carcinoma in situ; lobular neoplasia; atypical lobular hyperplasia; pleomorphic lobular carcinoma; invasive lobular carcinoma
Journal Title: American Journal of Surgical Pathology
Volume: 37
Issue: 7
ISSN: 0147-5185
Publisher: Lippincott Williams & Wilkins  
Date Published: 2013-07-01
Start Page: e1
End Page: e11
Language: English
DOI: 10.1097/PAS.0b013e3182918a2b
PROVIDER: scopus
PUBMED: 23759937
DOI/URL:
Notes: --- - "Export Date: 1 August 2013" - "CODEN: AJSPD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Britta Weigelt
    634 Weigelt
Related MSK Work